BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 26944831)

  • 1. miR-34a inhibits the in vitro cell proliferation and migration in human esophageal cancer.
    Shi H; Zhou S; Liu J; Zhu J; Xue J; Gu L; Chen Y
    Pathol Res Pract; 2016 May; 212(5):444-9. PubMed ID: 26944831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. STAT3 is involved in miR-124-mediated suppressive effects on esophageal cancer cells.
    Cheng Y; Li Y; Nian Y; Liu D; Dai F; Zhang J
    BMC Cancer; 2015 Apr; 15():306. PubMed ID: 25928665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of miR-34a contributes to the proliferation and migration of laryngeal carcinoma cells by targeting cyclin D1.
    Ye J; Li L; Feng P; Wan J; Li J
    Oncol Rep; 2016 Jul; 36(1):390-8. PubMed ID: 27220728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inactivation of miR-34a by aberrant CpG methylation in Kazakh patients with esophageal carcinoma.
    Cui X; Zhao Z; Liu D; Guo T; Li S; Hu J; Liu C; Yang L; Cao Y; Jiang J; Liang W; Liu W; Li S; Wang L; Wang L; Gu W; Wu C; Chen Y; Li F
    J Exp Clin Cancer Res; 2014 Feb; 33(1):20. PubMed ID: 24528540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-34a induces a senescence-like change via the down-regulation of SIRT1 and up-regulation of p53 protein in human esophageal squamous cancer cells with a wild-type p53 gene background.
    Ye Z; Fang J; Dai S; Wang Y; Fu Z; Feng W; Wei Q; Huang P
    Cancer Lett; 2016 Jan; 370(2):216-21. PubMed ID: 26523671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highly expressed microRNA-124 inhibits migration and promotes apoptosis of esophageal cancer cells by degrading PDCD6.
    Hu S; Zang R; Wang Y; Liang Y; Mu J; Zhang Y; Ma J
    J BUON; 2019; 24(2):805-812. PubMed ID: 31128039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-129-2 suppresses proliferation and migration of esophageal carcinoma cells through downregulation of SOX4 expression.
    Kang M; Li Y; Liu W; Wang R; Tang A; Hao H; Liu Z; Ou H
    Int J Mol Med; 2013 Jul; 32(1):51-8. PubMed ID: 23677061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and promotor hypermethylation of miR-34a in the various histological subtypes of ovarian cancer.
    Schmid G; Notaro S; Reimer D; Abdel-Azim S; Duggan-Peer M; Holly J; Fiegl H; Rössler J; Wiedemair A; Concin N; Altevogt P; Marth C; Zeimet AG
    BMC Cancer; 2016 Feb; 16():102. PubMed ID: 26879132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-205 functions as a tumor suppressor in adenocarcinoma and an oncogene in squamous cell carcinoma of esophagus.
    Hezova R; Kovarikova A; Srovnal J; Zemanova M; Harustiak T; Ehrmann J; Hajduch M; Sachlova M; Svoboda M; Slaby O
    Tumour Biol; 2016 Jun; 37(6):8007-18. PubMed ID: 26711784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting oncogenic PLCE1 by miR-145 impairs tumor proliferation and metastasis of esophageal squamous cell carcinoma.
    Cui XB; Li S; Li TT; Peng H; Jin TT; Zhang SM; Liu CX; Yang L; Shen YY; Li SG; Li N; Li Y; Hu JM; Jiang JF; Suo J; Qi Y; Liang WH; Wang LH; Dang HW; Li L; Cao WW; Wei Y; Laibo-Yin ; Wu CY; Yuan XL; Zhou H; Zheng Y; Chen YZ; Li F
    Oncotarget; 2016 Jan; 7(2):1777-95. PubMed ID: 26657507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-34a: a novel tumor suppressor in p53-mutant glioma cell line U251.
    Luan S; Sun L; Huang F
    Arch Med Res; 2010 Feb; 41(2):67-74. PubMed ID: 20470934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-34a inhibits migration and invasion of colon cancer cells via targeting to Fra-1.
    Wu J; Wu G; Lv L; Ren YF; Zhang XJ; Xue YF; Li G; Lu X; Sun Z; Tang KF
    Carcinogenesis; 2012 Mar; 33(3):519-28. PubMed ID: 22198213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression Level of miR-34a in Tumor Tissue from Patients with Esophageal Squamous Cell Carcinoma.
    Asadi M; Shanehbandi D; Mohammadpour H; Hashemzadeh S; Sepehri B
    J Gastrointest Cancer; 2019 Jun; 50(2):304-307. PubMed ID: 29453761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-chain non-coding RNA Linc00888 promotes the proliferation and migration of esophageal cancer cells by downregulating miR-34a expression.
    Zang HL; Li YH; Huang GM
    Eur Rev Med Pharmacol Sci; 2020 Nov; 24(21):11081-11089. PubMed ID: 33215424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic inactivation of DAPK1, p14ARF, mir-34a and -34b/c in acute promyelocytic leukaemia.
    Ng HY; Wan TS; So CC; Chim CS
    J Clin Pathol; 2014 Jul; 67(7):626-31. PubMed ID: 24811488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-126 is down-regulated in human esophageal squamous cell carcinoma and inhibits the proliferation and migration in EC109 cell via PI3K/AKT signaling pathway.
    Nie ZC; Weng WH; Shang YS; Long Y; Li J; Xu YT; Li Z
    Int J Clin Exp Pathol; 2015; 8(5):4745-54. PubMed ID: 26191164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-34a inhibits oral cancer progression partially by repression of interleukin-6-receptor.
    Li T; Li L; Li D; Wang S; Sun J
    Int J Clin Exp Pathol; 2015; 8(2):1364-73. PubMed ID: 25973020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-34a inhibits migration and invasion by regulating the SIRT1/p53 pathway in human SW480 cells.
    Lai M; Du G; Shi R; Yao J; Yang G; Wei Y; Zhang D; Xu Z; Zhang R; Li Y; Li Z; Wang L
    Mol Med Rep; 2015 May; 11(5):3301-7. PubMed ID: 25585539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CpG island methylation status of miRNAs in esophageal squamous cell carcinoma.
    Chen X; Hu H; Guan X; Xiong G; Wang Y; Wang K; Li J; Xu X; Yang K; Bai Y
    Int J Cancer; 2012 Apr; 130(7):1607-13. PubMed ID: 21547903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53-dependent activation of microRNA-34a in response to etoposide-induced DNA damage in osteosarcoma cell lines not impaired by dominant negative p53 expression.
    Novello C; Pazzaglia L; Conti A; Quattrini I; Pollino S; Perego P; Picci P; Benassi MS
    PLoS One; 2014; 9(12):e114757. PubMed ID: 25490093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.